PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Oventus Medical Ltd ( ) from 2016 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Oventus Medical stock (ASX:OVN) PE ratio as of Jun 04 2024 is 0. More Details

Oventus Medical Ltd (ASX:OVN) PE Ratio (TTM) Chart

To

Oventus Medical Ltd (ASX:OVN) PE Ratio (TTM) Historical Data

Total 1060
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 12
Oventus Medical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-04 At Loss 2023-05-22 At Loss
2023-07-21 At Loss 2023-05-19 At Loss
2023-07-20 At Loss 2023-05-18 At Loss
2023-07-19 At Loss 2023-05-17 At Loss
2023-07-18 At Loss 2023-05-16 At Loss
2023-07-17 At Loss 2023-05-15 At Loss
2023-07-14 At Loss 2023-05-12 At Loss
2023-07-13 At Loss 2023-05-11 At Loss
2023-07-12 At Loss 2023-05-10 At Loss
2023-07-11 At Loss 2023-05-09 At Loss
2023-07-10 At Loss 2023-05-08 At Loss
2023-07-07 At Loss 2023-05-05 At Loss
2023-07-06 At Loss 2023-05-04 At Loss
2023-07-05 At Loss 2023-05-03 At Loss
2023-07-04 At Loss 2023-05-02 At Loss
2023-07-03 At Loss 2023-05-01 At Loss
2023-06-30 At Loss 2023-04-28 At Loss
2023-06-29 At Loss 2023-04-27 At Loss
2023-06-28 At Loss 2023-04-26 At Loss
2023-06-27 At Loss 2023-04-25 At Loss
2023-06-26 At Loss 2023-04-24 At Loss
2023-06-23 At Loss 2023-04-21 At Loss
2023-06-22 At Loss 2023-04-20 At Loss
2023-06-21 At Loss 2023-04-19 At Loss
2023-06-20 At Loss 2023-04-18 At Loss
2023-06-19 At Loss 2023-04-17 At Loss
2023-06-16 At Loss 2023-04-14 At Loss
2023-06-15 At Loss 2023-04-13 At Loss
2023-06-14 At Loss 2023-04-12 At Loss
2023-06-13 At Loss 2023-04-11 At Loss
2023-06-12 At Loss 2023-04-10 At Loss
2023-06-09 At Loss 2023-04-07 At Loss
2023-06-08 At Loss 2023-04-06 At Loss
2023-06-07 At Loss 2023-04-05 At Loss
2023-06-06 At Loss 2023-04-04 At Loss
2023-06-05 At Loss 2023-04-03 At Loss
2023-06-02 At Loss 2023-03-31 At Loss
2023-06-01 At Loss 2023-03-30 At Loss
2023-05-31 At Loss 2023-03-29 At Loss
2023-05-30 At Loss 2023-03-28 At Loss
2023-05-29 At Loss 2023-03-27 At Loss
2023-05-26 At Loss 2023-03-24 At Loss
2023-05-25 At Loss 2023-03-23 At Loss
2023-05-24 At Loss 2023-03-22 At Loss
2023-05-23 At Loss 2023-03-21 At Loss

Oventus Medical Ltd (ASX:OVN) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.